From LawZero to PHAGEMIND: Building Ethical Superintelligence for Life Sciences
By Benoit Coulombe PhD
June 2025
In 2025, Professor Yoshua Bengio launched LawZero, a bold new initiative aimed at one of the greatest challenges of our time: aligning artificial intelligence with human values. At PHAGEMIND, we see this as a pivotal moment. Not only because LawZero tackles AI risk head-on, but because it affirms something we have believed since day one: In biology, alignment is not optional, it is vital.
The Challenge: What if AI Escapes Control
In recent years, AI systems have become dramatically more capable and correspondingly more unpredictable. As AI moves beyond predictive tasks into autonomous behavior, researchers have documented troubling behaviors: deceptive responses, self-preservation tactics, and goal misalignment.
Bengio’s concern, echoed across the AI safety community, is that we are designing agents whose power outpaces their alignment. This is not just a technical issue. It is an existential one.
For example, what happens when an AI interprets “optimize health” as “eliminate the sick”? What if a gene therapy design system is co-opted to produce bioweapons, all while “technically following instructions”? These are no longer hypotheticals. These are real red flags.
LawZero: The Case for Honest AI
LawZero proposes a radical shift: Instead of building AI agents that act, LawZero is developing Scientist AI, this is systems that evaluate, but do not execute. These AIs offer probabilistic reasoning rather than deterministic answers. They are specifically trained to recognize when they should not act or offer advice.
In other words, LawZero is creating an AI that is honest about its limits — an AI that can say “I don’t know.”
This aligns closely with the goals of open scientific inquiry. In Bengio’s own words: “A Scientist AI would be built from the ground up to be honest, humble, and helpful — not just smart.”
PHAGEMIND: Alignment with Biological Reality
PHAGEMIND operates in a parallel domain: instead of general-purpose AI safety, we are focused on biomedical superintelligence — a next-generation system that maps the human interactome to discover new epitope-based therapies.
Yet our principles are strikingly similar:
- Non-agentic design: Our system does not act autonomously. It interprets, predicts, and proposes, under human supervision.
- Biological alignment: Every model we deploy is grounded in the molecular and cellular logic of life.
- Ethical transparency: We prioritize explainability, traceability, and rigor in all algorithmic decisions.
Where LawZero focuses on AI’s societal risk, PHAGEMIND focuses on AI’s biological responsibility. We believe that biomedical AI must be held to a higher standard because the cost of misalignment is not just error: it is human harm.
Toward a Converging Ecosystem
LawZero and PHAGEMIND are not competitors. We are complementary forces working toward the same horizon: a world where intelligence, artificial or biological, is designed for good.
As the global conversation on AI safety deepens, we see an emerging ecosystem of actors who prioritize:
• Safety by design
• Scientific humility
• Human-aligned goals
• Structural safeguards
We deeply hope LawZero succeeds. We also hope PHAGEMIND becomes a case study in how domain-specific superintelligence can be aligned not just with goals, but with life’s complexity itself.
A Call to Collaboration
If you are working on aligned AI, ethical bioengineering, or the safe application of superintelligence in healthcare — we want to hear from you. PHAGEMIND is open to partnerships, shared protocols, and joint ethics frameworks.
Let’s move beyond AI for automation.
Let’s build AI for understanding.
Learn more:
#Superintelligence #AIAlignment #LawZero #PHAGEMIND #Bioethics #AIinBiomedicine #ResponsibleAI #YoshuaBengio #ScientistAI